Taronis Completes Successful Testing of Cyanobacteria Decontamination

Taronis Completes Successful Testing of Cyanobacteria Decontamination

Testing Independently Verified By Leading Environmental Testing Organizations   

TAMPA, FL, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Taronis Technologies, Inc. (“Taronis" or “the Company") (NASDAQ: MNGA), a leading clean technology company in the renewable resources and environmental conservation industry, today announced that the Company has successfully completed a study using its patented plasma arc technology to effectively kill toxic cyanobacteria and the related toxins produced by the bacteria. 

The testing involved four independent testing parties:  Florida State University, Tetra Tech, Enviro-Sciences, and Flowers Chemical Laboratories.  The water samples successfully tested were taken from Lake Okeechobee, in Central Florida, which was devastated by toxic cyanobacteria blooms during 2018.

Tetra Tech was engaged by Taronis to review the scope of testing and to observe the sampling, decontamination and review process.  Enviro-Sciences independently conducted testing related to the biological contents of the water samples before and after exposure to the plasma arc.     Flowers Chemical Laboratories is conducting independent testing on the chemical components of the water samples before and after exposure to the plasma arc.  Dr. Sven Kranz, of Florida State University, also independently observed all phases of testing and provided independent verification of the plasma arc’s ability to eliminate the cyanobacteria.  Dr. Kranz is an Assistant Professor of Oceanography within FSU’s Department of Earth, Ocean, and Atmospheric Science.

“This is a major scientific breakthrough for our Company,” commented Scott Mahoney, Chief Executive Officer of Taronis.  “Cyanobacteria overpopulation, commonly referred to as blue-green algae blooms, are increasing in frequency and encroaching on high population density regions within the US and globally.  Florida was devastated by these outbreaks in 2018, and we feel our technology could help address what is becoming a critical situation.”

Mr. Mahoney continued, “Cyanobacteria produce both neurotoxins and hepatotoxins that affect the nervous system and the liver, and are fatally toxic to humans.  These blooms are a leading cause of fish kills, and are a serious issue facing the global community. Florida’s state government has already recognized the severity of the issue, with Governor DeSantis announcing a $2.5 billion funding program over the next four years to address this and other issues related to Florida’s waterways.  In addition, the Governor formed a blue-green algae task force, which we intend to contact directly with our findings.  Our technology could play a key part in addressing this issue in Florida and beyond."  

About Taronis Technologies, Inc.
Taronis Technologies, Inc. (MNGA) owns a patented plasma arc technology that enables two primary end use applications for fuel generation and water decontamination.

The Company’s fuel technology enables a wide use of hydrocarbon feedstocks to be readily converted to fossil fuel substitutes.  The Company is developing a wide range of end market uses for these fuels, including replacement products for propane, compressed natural gas and liquid natural gas.  The Company currently markets a proprietary metal cutting fuel that is highly competitive with acetylene. The Company distributes its proprietary metal cutting fuel through Independent Distributors in the U.S and through its wholly owned distributors: ESSI, Green Arc Supply, Paris Oxygen, Latex Welding Supplies, Tyler Welders Supply, United Welding Supplies, Trico Welding Supply and Complete Welding of San Diego. The Company operates 17 locations across California, Texas, Louisiana, and Florida.

The Company’s technology can also be implemented for the decontamination of waste water, including sterilizing water, eradicating all pathogens.  The technology is being tested to determine if it can completely eliminate pharmaceutical contaminants such as antibiotics, hormones and other soluble drugs suspended in contaminated water. Lastly, the technology  process is capable of reducing or eliminating other contaminants, such as harmful metals, as well as nitrogen, phosphorus, and potassium levels that trigger toxic algae blooms.  The technology has prospective commercial applications in the agricultural, pharmaceutical, and municipal waste markets.  For more information on Taronis, please visit the Company's website at http://www.TaronisTech.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov

Investor Contacts:
Andrew Gibson
Edison Group
taronis@edisongroup.com